Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs BETA DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA BETA DRUGS GRANULES INDIA/
BETA DRUGS
 
P/E (TTM) x 25.3 - - View Chart
P/BV x 3.5 10.9 32.5% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 GRANULES INDIA   BETA DRUGS
EQUITY SHARE DATA
    GRANULES INDIA
Mar-23
BETA DRUGS
Mar-23
GRANULES INDIA/
BETA DRUGS
5-Yr Chart
Click to enlarge
High Rs3811,024 37.2%   
Low Rs227546 41.6%   
Sales per share (Unadj.) Rs186.4236.3 78.9%  
Earnings per share (Unadj.) Rs21.332.0 66.8%  
Cash flow per share (Unadj.) Rs29.042.8 67.7%  
Dividends per share (Unadj.) Rs1.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs116.4127.9 91.0%  
Shares outstanding (eoy) m242.049.61 2,518.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.63.3 49.1%   
Avg P/E ratio x14.224.6 58.0%  
P/CF ratio (eoy) x10.518.4 57.2%  
Price / Book Value ratio x2.66.1 42.5%  
Dividend payout %7.00-   
Avg Mkt Cap Rs m73,6117,549 975.1%   
No. of employees `000NANA-   
Total wages/salary Rs m4,203171 2,461.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m45,1192,271 1,986.6%  
Other income Rs m1438 1,894.8%   
Total revenues Rs m45,2622,279 1,986.3%   
Gross profit Rs m9,133531 1,719.1%  
Depreciation Rs m1,845104 1,772.3%   
Interest Rs m55924 2,316.1%   
Profit before tax Rs m6,872411 1,673.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,706103 1,650.0%   
Profit after tax Rs m5,166307 1,681.7%  
Gross profit margin %20.223.4 86.5%  
Effective tax rate %24.825.2 98.6%   
Net profit margin %11.413.5 84.7%  
BALANCE SHEET DATA
Current assets Rs m25,7411,344 1,915.7%   
Current liabilities Rs m18,135697 2,601.7%   
Net working cap to sales %16.928.5 59.2%  
Current ratio x1.41.9 73.6%  
Inventory Days Days1411 132.7%  
Debtors Days Days771,008 7.6%  
Net fixed assets Rs m23,290695 3,349.3%   
Share capital Rs m24296 251.8%   
"Free" reserves Rs m27,9271,133 2,465.5%   
Net worth Rs m28,1691,229 2,292.3%   
Long term debt Rs m1,48670 2,131.4%   
Total assets Rs m49,0312,039 2,404.6%  
Interest coverage x13.318.0 73.8%   
Debt to equity ratio x0.10.1 93.0%  
Sales to assets ratio x0.91.1 82.6%   
Return on assets %11.716.2 71.9%  
Return on equity %18.325.0 73.4%  
Return on capital %25.133.5 74.9%  
Exports to sales %81.012.3 660.7%   
Imports to sales %31.30.2 14,113.0%   
Exports (fob) Rs m36,526278 13,125.1%   
Imports (cif) Rs m14,1205 280,151.0%   
Fx inflow Rs m36,526278 13,116.1%   
Fx outflow Rs m14,12048 29,440.4%   
Net fx Rs m22,406231 9,719.8%   
CASH FLOW
From Operations Rs m7,387234 3,159.5%  
From Investments Rs m-1,914-191 1,003.5%  
From Financial Activity Rs m-4,403-25 17,796.7%  
Net Cashflow Rs m1,06818 5,806.7%  

Share Holding

Indian Promoters % 41.6 66.7 62.4%  
Foreign collaborators % 0.4 0.0 -  
Indian inst/Mut Fund % 30.3 0.4 8,408.3%  
FIIs % 19.6 0.3 6,115.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 33.3 174.5%  
Shareholders   182,142 2,116 8,607.8%  
Pledged promoter(s) holding % 4.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GRANULES INDIA vs BETA DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GRANULES INDIA vs BETA DRUGS Share Price Performance

Period GRANULES INDIA BETA DRUGS S&P BSE HEALTHCARE
1-Day -0.71% 1.09% -0.12%
1-Month -0.23% 14.49% 2.49%
1-Year 35.71% 77.03% 50.31%
3-Year CAGR 6.50% 112.81% 14.33%
5-Year CAGR 28.60% 67.56% 19.27%

* Compound Annual Growth Rate

Here are more details on the GRANULES INDIA share price and the BETA DRUGS share price.

Moving on to shareholding structures...

The promoters of GRANULES INDIA hold a 42.0% stake in the company. In case of BETA DRUGS the stake stands at 66.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GRANULES INDIA and the shareholding pattern of BETA DRUGS .

Finally, a word on dividends...

In the most recent financial year, GRANULES INDIA paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 7.0%.

BETA DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of GRANULES INDIA, and the dividend history of BETA DRUGS .

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 500 Points Amid Iran-Israel Tensions | Nifty Below 21,850 | All Sectors in Red Sensex Today Tanks 500 Points Amid Iran-Israel Tensions | Nifty Below 21,850 | All Sectors in Red(10:30 am)

Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.